Clinical Research Directory
Browse clinical research sites, groups, and studies.
Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Summary
One-center observational study aimed at determining the survival of patients with rheumatoid arthritis treated with targeted synthetic disease-modifying drugs (FAMEsd) and biologic disease-modifying drugs (FAMEb). These patients will be administered a series of medications and a follow-up will be carried out to analyze their evolution.
Official title: Persistence of Biological Treatment and Inhibitors of Jak Kinases in Habitual Clinical Practice in Patients With Rheumatoid Arthritis. Influence of the Comorbidities.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
540
Start Date
2021-04-01
Completion Date
2026-12-31
Last Updated
2021-11-17
Healthy Volunteers
No
Conditions
Locations (1)
Hospital Universitario Virgen macarena
Seville, Spain